# Functional Neuroimaging in Depression

> **NCT00343070** · PHASE2 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 40 (estimated)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** Oral administration of escitalopram during 8 weeks

## Key facts

- **NCT ID:** NCT00343070
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-08-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343070, "Functional Neuroimaging in Depression". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00343070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*